Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino M, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis. Circulation. 2017 Aug 08;136(6):529-545. \[[PubMed: 28576783](https://pubmed.ncbi.nlm.nih.gov/28576783)\] 25. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation. 2003 Feb 18;107(6):857-63. \[[PubMed: 12591756](https://pubmed.ncbi.nlm.nih.gov/12591756)\] 26. Veronese G, Ammirati E, Cipriani M, Frigerio M. Fulminant myocarditis: Characteristics, treatment, and outcomes. Anatol J Cardiol. 2018 Apr;19(4):279-286. \[[PMC free article: PMC5998855](/pmc/articles/PMC5998855/)\] \[[PubMed: 29537977](https://pubmed.ncbi.nlm.nih.gov/29537977)\] 27. Godishala A, Yang S, Asnani A. Cardioprotection in the Modern Era of Cancer Chemotherapy. Cardiol Rev. 2018 May/Jun;26(3):113-121. \[[PubMed: 29608498](https://pubmed.ncbi.nlm.nih.gov/29608498)\] 28. Zheng YM, Yang J, Liao QH. [Health related quality of life on severe hand, foot and mouth disease patients]. Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Apr 10;38(4):462-466. \[[PubMed: 28468063](https://pubmed.ncbi.nlm.nih.gov/28468063)\] **Disclosure:** Pirbhat Shams declares no relevant financial relationships with ineligible companies. **Disclosure:** Sara Collier declares no relevant financial relationships with ineligible companies.